New perspectives on the therapeutic potential of quercetin in non-communicable diseases: Targeting Nrf2 to counteract oxidative stress and inflammation
Li Zhang,Li Yue Xu,Fei Tang,Dong Liu,Xiao Lan Zhao,Jing Nan Zhang,Jia Xia,Jiao Jiao Wu,Yu Yang,Cheng Peng,Hui Ao
DOI: https://doi.org/10.1016/j.jpha.2023.12.020
IF: 14.026
2024-01-04
Journal of Pharmaceutical Analysis
Abstract:Highlights • Quercetin, a readily available flavonoid, shows promise in anti-NCDs by strongly binding to Nrf2. • Nrf2-targeted Quercetin demonstrates robust antioxidant and anti-inflammatory capabilities. • Quercetin via Nrf2 modulates mitochondria, apoptosis, autophagy, bolstering anti-NCD potential. Non-communicable diseases (NCDs), including cardiovascular diseases, cancer, metabolic diseases, and skeletal diseases, pose significant challenges to public health worldwide. The complex pathogenesis of these diseases is closely linked to oxidative stress and inflammatory damage. Nuclear factor erythroid 2-related factor 2 (Nrf2), a critical transcription factor, plays an important role in regulating antioxidant and anti-inflammatory responses to protect the cells from oxidative damage and inflammation-mediated injury. Therefore, Nrf2 -targeting therapies hold promise for preventing and treating NCDs. Quercetin (Que) is a widely available flavonoid that has significant antioxidant and anti-inflammatory properties. It modulates the Nrf2 signaling pathway to ameliorate oxidative stress and inflammation. Que modulates mitochondrial function, apoptosis, autophagy, and cell damage biomarkers to regulate oxidative stress and inflammation, highlighting its efficacy as a therapeutic agent against NCDs. Here, we discussed, for the first time, the close association between NCD pathogenesis and the Nrf2 signaling pathway, involved in neurodegenerative diseases, cardiovascular disease, cancers, organ damage, and bone damage. Furthermore, we reviewed the availability, pharmacokinetics, pharmaceutics, and therapeutic applications of Que in treating NCDs. In addition, we focused on the challenges and prospects for its clinical use. Que represents a promising candidate for the treatment of NCDs due to its Nrf2 -targeting properties. Graphical abstract Download : Download high-res image (272KB) Download : Download full-size image
pharmacology & pharmacy